A Q2 2025 Earnings — Agilent Technologies, Inc. Revenue & Financial Results | Market Cap Arena

AAgilent Technologies, Inc.

$33B

Q2 2025 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.7B+6.0% YoY

Gross Profit

$866M51.9% margin

Operating Income

$300M18.0% margin

Net Income

$215M12.9% margin

EPS (Diluted)

$0.75

QoQ Revenue Growth

-0.8%

Cash Flow

Operating Cash Flow

$221M

Free Cash Flow

$107M

Stock-Based Comp.

$30M

Balance Sheet

Total Assets

$12.2B

Total Liabilities

$6.0B

Stockholders' Equity

$6.1B

Cash & Equivalents

$1.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.7B	$1.6B	+6.0%
Gross Profit	$866M	$856M	+1.2%
Operating Income	$300M	$363M	-17.4%
Net Income	$215M	$308M	-30.2%

Revenue Segments

Agilent CrossLab

$713M43%

Life Sciences and Applied Markets

$654M39%

Applied Markets

$301M18%

Geographic Segments

Americas

$678M41%

Asia Pacific

$548M33%

Europe

$442M26%